Repos Pharma Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Repos Pharma General Information

Description

Operator of a drug research and development company designed to offer treatment for cancer disease to patients. The company offers re-profiling drugs for treating additional forms of cancer, enabling cancer patients to begin their treatment and get successful cures for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Bredgrand 14
  • 753 20 Uppsala
  • Sweden

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Repos Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view Repos Pharma’s complete valuation and funding history, request access »

Repos Pharma Patents

Repos Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210015797-A1 Treatment for inflammatory disease Active 19-Dec-2017 00000000000
US-11504356-B2 Treatment for inflammatory disease Active 19-Dec-2017 00000000000 0
AU-2018387255-A1 Treatment for inflammatory disease Pending 19-Dec-2017 00000000000
CA-3086101-A1 Treatment for inflammatory disease Pending 19-Dec-2017 00000000000
EP-3727373-A2 Treatment for inflammatory disease Pending 19-Dec-2017 A61K31/4184
To view Repos Pharma’s complete patent history, request access »

Repos Pharma Executive Team (2)

Name Title Board Seat Contact Info
Sven Mårten Fryknäs Co-Founder, Chief Executive Officer, Managing Director & Board Member
Angelica Loskog President & Chairman
To view Repos Pharma’s complete executive team members history, request access »

Repos Pharma Board Members (3)

Name Representing Role Since
Angelica Loskog Self President & Chairman 000 0000
Hans Nygren Self Board Member 000 0000
Rolf Larsson Self Board Member 000 0000
To view Repos Pharma’s complete board members history, request access »

Repos Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nxt2b Venture Capital Minority 000 0000 000000 0
To view Repos Pharma’s complete investors history, request access »